the u.s. will hit 100 million shots in arms and another date, may 1st, listen to this. all adult americans will be eligible to get a vaccine to later than may 1. let me be clear. that doesn t mean everyone is going to have that shot immediately. but it means you ll be able to get in line beginning may 1. and then there is july 4th when the president said he aims for the country to be able to gather safely once again with loved ones. how does the administration meet and exceed these markers. that is one major question. also when every adult is eligible for a ashot how do they make sure everyone gets that shot quickly and president biden wants families to be able to gathered with loved ones on july 4th. does he mean be able to travel to get together with loved ones? he may have some answers. we ll bring you when the briefing begins, we ll bring it to you when they start speaking. and a few hours from now, another big event at the white house. a ceremonial bill signing of th
On Monday, Vincerx Pharma Inc (NASDAQ:VINC) presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the American Association for Cancer Research Annual Meeting 2024. VNC-236-101 is a Phase 1 dose-escalation study with monotherapy VIP236 for metastatic tumor patients who have exhausted all standard therapy options. Fifteen patients have been dosed to date on the once-every-three-weeks (Q3W) schedule: The Q3W schedule is well tolerated with no dose-limiting toxicity (DLT)
The European Commission has approved the Menarini Group’s Orsedu (elacestrant) as a monotherapy for the treatment of postmenopausal women and men with breast cancer.
Italy: Recent research has demonstrated superior efficacy and similar overall safety of P2Y12 inhibitor monotherapy over aspirin monotherapy for long-term secondary prevention in patients with.
Findings from the ongoing Phase 1 MYTHIC study demonstrated a favorable and distinctive tolerability profile for monotherapy lunresertib
Monotherapy antitumor activity observed, including confirmed. | June 7, 2023